Guidance Point Advisors, LLC Pfizer Inc Transaction History

Guidance Point Advisors, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 05, 2022	SELL	$45.75 - $56.69 $161,360 - $199,945	-3,527 Closed	0 $0
Q4 2021 Jan 28, 2022	BUY	$41.32 - $61.25 $247 - $367	6 Added 0.17%	3,527 $208,000
Q3 2021 Oct 20, 2021	BUY	$39.25 - $50.42 $138,199 - $177,528	3,521 New	3,521 $151,000
Q3 2019 Oct 08, 2019	SELL	$32.49 - $42.13 $161,475 - $209,386	-4,970 Closed	0 $0
Q2 2019 Aug 05, 2019	BUY	$36.98 - $41.52 $739 - $830	20 Added 0.4%	4,970 $215,000
Q1 2019 May 06, 2019	BUY	$37.5 - $41.2 $750 - $824	20 Added 0.41%	4,950 $210,000
Q4 2018 Feb 13, 2019	BUY	$38.47 - $43.86 $189,657 - $216,229	4,930 New	4,930 $215,000

3,257

3.62B

77.2M

122M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $139B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Guidance Point Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Guidance Point Advisors, LLC with notifications on news.